Tralokinumab
Encyclopedia
Tralokinumab is a human monoclonal antibody designed for the treatment of asthma
and inflammatory diseases.
Tralokinumab was developed by MedImmune
.
Asthma
Asthma is the common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include wheezing, coughing, chest tightness, and shortness of breath...
and inflammatory diseases.
Tralokinumab was developed by MedImmune
MedImmune
MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise...
.